Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection (Q84590122)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814408 AND SRC:MED&resulttype=core&format=json

8 February 2020

title

Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814408 AND SRC:MED&resulttype=core&format=json

8 February 2020

Lactococcus lactis

1 reference

Leishmania major

1 reference

Felix Hugentobler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814408 AND SRC:MED&resulttype=core&format=json

8 February 2020

Raphaël B Di Roberto

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814408 AND SRC:MED&resulttype=core&format=json

8 February 2020

Joshua Gillard

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814408 AND SRC:MED&resulttype=core&format=json

8 February 2020

Benoit Cousineau

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814408 AND SRC:MED&resulttype=core&format=json

8 February 2020

publication date

17 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814408 AND SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814408 AND SRC:MED&resulttype=core&format=json

8 February 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814408 AND SRC:MED&resulttype=core&format=json

8 February 2020

issue

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814408 AND SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

5726-5732

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814408 AND SRC:MED&resulttype=core&format=json

Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Leishmania antimony resistance: what we know what we can learn from the field.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Cell biology and immunology of Leishmania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

The immunology of susceptibility and resistance to Leishmania major in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Expression cloning of a protective Leishmania antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Protective immune response against cutaneous leishmaniasis by prime/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36/LACK and IL-12 in combination with purified p36.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

The combination of DNA vectors expressing IL-12 IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Intranasal vaccination against cutaneous leishmaniasis with a particulated leishmanial antigen or DNA encoding LACK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Listeria monocytogenes as a short-lived delivery system for the induction of type 1 cell-mediated immunity against the p36/LACK antigen of Leishmania major

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

DNA-Salmonella enterica serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Immunization against Leishmania major infection using LACK- and IL-12-expressing Lactococcus lactis induces delay in footpad swelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Safety assessment of dairy microorganisms: the Lactococcus genus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Lactococcus lactis as a cell factory for delivery of therapeutic proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Generation and evaluation of A2-expressing Lactococcus lactis live vaccines against Leishmania donovani in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

HtrA is essential for efficient secretion of recombinant proteins by Lactococcus lactis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Leishmania parasite detection and quantification using PCR-ELISA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Autolysis of Lactococcus lactis is increased upon D-alanine depletion of peptidoglycan and lipoteichoic acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Effect of intragastric and intraperitoneal immunisation with attenuated and wild-type LACK-expressing Listeria monocytogenes on control of murine Leishmania major infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Use of live bacterial vaccine vectors for antigen delivery: potential and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Development of vaccine delivery vehicles based on lactic acid bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Leishmaniasis Vaccine: Where are We Today?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

A role for IgG immune complexes during infection with the intracellular pathogen Leishmania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

The Relative Contribution of IL-4 Receptor Signaling and IL-10 to Susceptibility toLeishmania major

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2012.07.004

10.1016/J.VACCINE.2012.07.004

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22814408 AND SRC:MED&resulttype=core&format=json

8 February 2020

1 reference